BAM
AVEO

Belpointe Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Belpointe Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$14.9K – 3931
2022
Q4 		$14.9K Buy
+1,000
New +$13.8K ﹤0.01% 2399

Belpointe Asset Management's AVEO Position: Q1 2023 in Review

Belpointe Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,000 shares — an estimated $14.9K sold.

Belpointe Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $14.9K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Belpointe Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 1,000 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $14.9K.
  • Belpointe Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $14.9K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.